Company · CIK 1625297

# Indivior Pharmaceuticals, Inc.

| CIK | [1625297](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001625297) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | VA |
| Listed | INDV (Nasdaq) |
| First annual or quarterly report | 2024-03-06 |

## Offerings

 0 registrations

No offering chain starts here after 2002-11-04: the company's filings belong to registrations filed earlier, or to drafts and notices only.

## Filings

 3

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-09-11 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1625297/999999999526002953/9999999995-26-002953-index.htm) Declared effective | 333-298637 | 9999999995-26-002953 |
| 2022-11-22 | [DRS](https://www.sec.gov/Archives/edgar/data/1625297/000162828022030627/0001628280-22-030627-index.htm) Draft made public | 377-06470 | 0001628280-22-030627 |
| 2014-12-23 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1625297/999999999514003801/9999999995-14-003801-index.htm) Declared effective | 333-200689 | 9999999995-14-003801 |

[All filings of this company](https://equitycapital.markets/filings?cik=1625297) · [CSV](https://equitycapital.markets/filings.csv?cik=1625297)

---
Source page: https://equitycapital.markets/company/1625297 · Data: U.S. SEC EDGAR · CC BY 4.0